Lic. Den Alejandro Alvarado Velázquez
Ex-colaborador y/o ex-alumno
Total de publicaciones: 2
- Tipo
- Fecha
Artículo
1 - Sandoval-Hernandez,M.A., Fierro,N.A., Veytia-Bucheli,J.I., Alvarado-Velazquez,D.A., Aleman-Navarro,E., Melchy-Perez,E., Auvynet,C., Imaz-Rosshandler,I., Carneiro,J., Perez-Rueda,E., Rosenstein,Y. (2024). Differential Impact of CD43 and CD28 on T-Cell Differentiation Depending on the Order of Engagement with the TCR.
International Journal of Molecular Sciences,
25 (6),
3135.
Artículo
2 - Veytia-Bucheli,J.I., Alvarado-Velazquez,D.A., Possani,L.D., Gonzalez-Amaro,R., Rosenstein,Y. (2022). The Ca(2+) Channel Blocker Verapamil Inhibits the In Vitro Activation and Function of T Lymphocytes: A 2022 Reappraisal.
Pharmaceutics,
14 (7).
Artículo
3 - Sandoval-Hernandez,M.A., Fierro,N.A., Veytia-Bucheli,J.I., Alvarado-Velazquez,D.A., Aleman-Navarro,E., Melchy-Perez,E., Auvynet,C., Imaz-Rosshandler,I., Carneiro,J., Perez-Rueda,E., Rosenstein,Y.. Differential Impact of CD43 and CD28 on T-Cell Differentiation Depending on the Order of Engagement with the TCR.
International Journal of Molecular Sciences,
25 (6),
3135.
Artículo
4 - Veytia-Bucheli,J.I., Alvarado-Velazquez,D.A., Possani,L.D., Gonzalez-Amaro,R., Rosenstein,Y.. The Ca(2+) Channel Blocker Verapamil Inhibits the In Vitro Activation and Function of T Lymphocytes: A 2022 Reappraisal.
Pharmaceutics,
14 (7).